Juncture Wealth Strategies, LLC Novartis Ag Transaction History

Juncture Wealth Strategies, LLC

$258 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$95.27 - $108.47 $28,390 - $32,324	-298 Reduced 4.81%	5,900 $570,000
Q4 2023 Jan 08, 2024	BUY	$92.27 - $101.54 $18,454 - $20,308	200 Added 3.33%	6,198 $625,000
Q3 2023 Oct 10, 2023	SELL	$94.73 - $105.13 $9,473 - $10,513	-100 Reduced 1.64%	5,998 $610,000
Q2 2023 Jul 11, 2023	SELL	$92.52 - $104.91 $9,437 - $10,700	-102 Reduced 1.65%	6,098 $615,000
Q1 2023 May 05, 2023	SELL	$80.03 - $92.81 $24,009 - $27,843	-300 Reduced 4.62%	6,200 $570,000
Q4 2022 Jan 18, 2023	SELL	$75.55 - $92.52 $7,555 - $9,252	-100 Reduced 1.52%	6,500 $0
Q3 2022 Oct 11, 2022	BUY	$74.61 - $87.26 $44,766 - $52,356	600 Added 10.0%	6,600 $502,000
Q2 2022 Jul 14, 2022	BUY	$80.52 - $93.75 $16,104 - $18,750	200 Added 3.45%	6,000 $507,000
Q1 2022 Jul 14, 2022	BUY	$80.11 - $90.62 $40,055 - $45,310	500 Added 9.43%	5,800 $509,000
Q3 2021 Oct 15, 2021	BUY	$81.78 - $95.14 $32,712 - $38,056	400 Added 8.16%	5,300 $433,000
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $25,572 - $28,245	-300 Reduced 5.77%	4,900 $452,000
Q4 2020 Jan 25, 2021	BUY	$78.07 - $94.43 $78,070 - $94,430	1,000 Added 23.81%	5,200 $491,000
Q3 2020 Oct 15, 2020	SELL	$82.14 - $91.0 $24,642 - $27,300	-300 Reduced 6.67%	4,200 $365,000
Q2 2020 Jul 28, 2020	BUY	$80.93 - $91.1 $56,651 - $63,769	700 Added 18.42%	4,500 $393,000
Q1 2020 Apr 21, 2020	SELL	$70.67 - $99.01 $120,139 - $168,317	-1,700 Reduced 30.91%	3,800 $313,000
Q4 2019 Feb 03, 2020	SELL	$84.35 - $95.37 $8,435 - $9,537	-100 Reduced 1.79%	5,500 $521,000
Q3 2019 Oct 10, 2019	BUY	$85.54 - $94.26 $25,662 - $28,278	300 Added 5.66%	5,600 $487,000
Q2 2019 Jul 16, 2019	SELL	$75.4 - $92.8 $7,540 - $9,280	-100 Reduced 1.85%	5,300 $484,000
Q1 2019 Apr 09, 2019	BUY	$75.32 - $86.15 $112,979 - $129,225	1,500 Added 38.46%	5,400 $519,000
Q4 2018 Jan 17, 2019	SELL	$73.66 - $82.02 $66,294 - $73,818	-900 Reduced 18.75%	3,900 $335,000
Q3 2018 Oct 03, 2018	SELL	$66.94 - $77.43 $6,694 - $7,743	-100 Reduced 2.04%	4,800 $414,000
Q2 2018 Jul 13, 2018	BUY	$64.91 - $73.36 $25,964 - $29,344	400 Added 8.89%	4,900 $370,000
Q1 2018 Apr 25, 2018	SELL	$70.39 - $84.15 $35,195 - $42,075	-500 Reduced 10.0%	4,500 $364,000
Q4 2017 Jan 22, 2018	BUY	$72.33 - $77.64 $115,728 - $124,224	1,600 Added 47.06%	5,000 $420,000
Q3 2017 Oct 18, 2017	BUY	$74.14 - $77.27 $252,076 - $262,718	3,400	3,400 $292,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Juncture Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Juncture Wealth Strategies, LLC with notifications on news.

Account